These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

926 related articles for article (PubMed ID: 37371524)

  • 21. Role of epigenetics in carcinogenesis: Recent advancements in anticancer therapy.
    Hussain S; Tulsyan S; Dar SA; Sisodiya S; Abiha U; Kumar R; Mishra BN; Haque S
    Semin Cancer Biol; 2022 Aug; 83():441-451. PubMed ID: 34182144
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reprogramming cancer cells: a novel approach for cancer therapy or a tool for disease-modeling?
    Yilmazer A; de Lázaro I; Taheri H
    Cancer Lett; 2015 Dec; 369(1):1-8. PubMed ID: 26276716
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Calcium signaling and epigenetics: A key point to understand carcinogenesis.
    Izquierdo-Torres E; Hernández-Oliveras A; Fuentes-García G; Zarain-Herzberg Á
    Cell Calcium; 2020 Nov; 91():102285. PubMed ID: 32942140
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metabolic reprogramming in glioblastoma: the influence of cancer metabolism on epigenetics and unanswered questions.
    Agnihotri S; Zadeh G
    Neuro Oncol; 2016 Feb; 18(2):160-72. PubMed ID: 26180081
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Research advances on epigenetics and cancer metabolism.
    Han H; Feng F; Li H
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2021 Feb; 50(1):1-16. PubMed ID: 34117859
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cancer Epigenetics: An Overview.
    Recillas-Targa F
    Arch Med Res; 2022 Dec; 53(8):732-740. PubMed ID: 36411173
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Unveiling epigenetic regulation in cancer, aging, and rejuvenation with in vivo reprogramming technology.
    Sogabe Y; Seno H; Yamamoto T; Yamada Y
    Cancer Sci; 2018 Sep; 109(9):2641-2650. PubMed ID: 29989289
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epigenetics and metabolism at the crossroads of stress-induced plasticity, stemness and therapeutic resistance in cancer.
    Ravindran Menon D; Hammerlindl H; Torrano J; Schaider H; Fujita M
    Theranostics; 2020; 10(14):6261-6277. PubMed ID: 32483452
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epigenetics and Cancer Stem Cells: Unleashing, Hijacking, and Restricting Cellular Plasticity.
    Wainwright EN; Scaffidi P
    Trends Cancer; 2017 May; 3(5):372-386. PubMed ID: 28718414
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epigenetics and cancer metabolism.
    Johnson C; Warmoes MO; Shen X; Locasale JW
    Cancer Lett; 2015 Jan; 356(2 Pt A):309-14. PubMed ID: 24125862
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metabolic alteration in tumorigenesis.
    Yang H; Xiong Y; Guan K
    Sci China Life Sci; 2013 Dec; 56(12):1067-75. PubMed ID: 24114443
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Review: Regulation of the cancer epigenome by long non-coding RNAs.
    Forrest ME; Khalil AM
    Cancer Lett; 2017 Oct; 407():106-112. PubMed ID: 28400335
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epigenetic plasticity and the hallmarks of cancer.
    Flavahan WA; Gaskell E; Bernstein BE
    Science; 2017 Jul; 357(6348):. PubMed ID: 28729483
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epigenetics in cancer: targeting chromatin modifications.
    Ellis L; Atadja PW; Johnstone RW
    Mol Cancer Ther; 2009 Jun; 8(6):1409-20. PubMed ID: 19509247
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serine and one-carbon metabolism, a bridge that links mTOR signaling and DNA methylation in cancer.
    Zeng JD; Wu WKK; Wang HY; Li XX
    Pharmacol Res; 2019 Nov; 149():104352. PubMed ID: 31323332
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Promoter DNA Hypermethylation and Paradoxical Gene Activation.
    Smith J; Sen S; Weeks RJ; Eccles MR; Chatterjee A
    Trends Cancer; 2020 May; 6(5):392-406. PubMed ID: 32348735
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gerometabolites: the pseudohypoxic aging side of cancer oncometabolites.
    Menendez JA; Alarcón T; Joven J
    Cell Cycle; 2014; 13(5):699-709. PubMed ID: 24526120
    [TBL] [Abstract][Full Text] [Related]  

  • 38. DNA methylation reprogramming in cancer: does it act by re-configuring the binding landscape of Polycomb repressive complexes?
    Reddington JP; Sproul D; Meehan RR
    Bioessays; 2014 Feb; 36(2):134-40. PubMed ID: 24277643
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epigenetics and cancer, 2nd IARC meeting, Lyon, France, 6 and 7 December 2007.
    Lambert MP; Herceg Z
    Mol Oncol; 2008 Jun; 2(1):33-40. PubMed ID: 19383327
    [TBL] [Abstract][Full Text] [Related]  

  • 40. DNA methylation, histone acetylation and methylation of epigenetic modifications as a therapeutic approach for cancers.
    Yen CY; Huang HW; Shu CW; Hou MF; Yuan SS; Wang HR; Chang YT; Farooqi AA; Tang JY; Chang HW
    Cancer Lett; 2016 Apr; 373(2):185-92. PubMed ID: 26808576
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 47.